These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17541571)

  • 1. Pharmacokinetics of morphine-6-glucuronide following oral administration in healthy volunteers.
    Villesen HH; Kristensen K; Hansen SH; Jensen NH; Skram U; Christrup LL
    Eur J Clin Pharmacol; 2007 Aug; 63(8):761-7. PubMed ID: 17541571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide.
    Penson RT; Joel SP; Roberts M; Gloyne A; Beckwith S; Slevin ML
    Br J Clin Pharmacol; 2002 Apr; 53(4):347-54. PubMed ID: 11966664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories.
    Du X; Skopp G; Aderjan R
    Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers.
    Lötsch J; Weiss M; Ahne G; Kobal G; Geisslinger G
    Anesthesiology; 1999 Apr; 90(4):1026-38. PubMed ID: 10201674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
    Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
    Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.
    Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML
    Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal absorption and stability of morphine 6-glucuronide in different physiological compartments of the rat.
    Stain-Texier F; Sandouk P; Scherrmann JM
    Drug Metab Dispos; 1998 May; 26(5):383-7. PubMed ID: 9571218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.
    Klimas R; Mikus G
    Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.
    Hasselström J; Säwe J
    Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
    Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
    Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine.
    Kinzler ER; Pantaleon C; Iverson M; Aigner S
    Adv Ther; 2019 Sep; 36(9):2394-2401. PubMed ID: 31278694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.
    Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G
    Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide.
    de Hoogd S; Välitalo PAJ; Dahan A; van Kralingen S; Coughtrie MMW; van Dongen EPA; van Ramshorst B; Knibbe CAJ
    Clin Pharmacokinet; 2017 Dec; 56(12):1577-1587. PubMed ID: 28510797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers.
    Lötsch J; Skarke C; Schmidt H; Liefhold J; Geisslinger G
    Clin Pharmacol Ther; 2002 Aug; 72(2):151-62. PubMed ID: 12189362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
    Quigley C; Joel S; Patel N; Baksh A; Slevin M
    Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain.
    De Gregori S; Minella CE; De Gregori M; Tinelli C; Ranzani GN; Govoni S; Allegri M; Regazzi M
    Ther Drug Monit; 2014 Jun; 36(3):335-44. PubMed ID: 24595069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose.
    Velez de Mendizabal N; Jimenez-Mendez R; Cooke E; Montgomery CJ; Dawes J; Rieder MJ; Aleksa K; Koren G; Jacobo-Cabral CO; Gonzalez-Ramirez R; Castañeda-Hernandez G; Carleton BC
    Clin Pharmacokinet; 2015 Oct; 54(10):1083-90. PubMed ID: 25773480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers.
    Murthy BR; Pollack GM; Brouwer KL
    J Clin Pharmacol; 2002 May; 42(5):569-76. PubMed ID: 12017351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy, safety and pharmacokinetics of a newly developed controlled release morphine sulphate suppository in patients with cancer pain.
    Moolenaar F; Meijler WJ; Frijlink HW; Visser J; Proost JH
    Eur J Clin Pharmacol; 2000 Jun; 56(3):219-23. PubMed ID: 10952476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.
    Klepstad P; Dale O; Kaasa S; Zahlsen K; Aamo T; Fayers P; Borchgrevink PC
    Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.